WallStreetZenWallStreetZen

NASDAQ: BBIO
Bridgebio Pharma Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Bridgebio Pharma revenue was $353.78M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $120.7M, up 9.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BBIO annual revenue was $221.9M, with 2,285.3% growth year-over-year.

BBIO past revenue growth

How has BBIO's revenue growth performed historically?

Company
62.46%
Industry
273.12%
Market
22.22%
BBIO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BBIO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BBIO's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BBIO revenue history

Current Revenue
$353.8M
Current Earnings
-$797.1M
Current Profit Margin
-225.3%

Be the first to know when BBIO announces revenue.

BBIO Revenue History By Year

BBIO Yearly RevenueBBIO RevenueBBIO ChangeBBIO Revenue Growth
2024-12-31$221.90M$212.60M+2,285.27%
2023-12-31$9.30M-$68.35M-88.02%
2022-12-31$77.65M$7.93M+11.38%
2021-12-31$69.72M$61.47M+745.14%
2020-12-31$8.25M-$32.31M-79.66%
2019-12-31$40.56MN/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A

1 of 1

Bridgebio Pharma Revenue FAQ

What was BBIO's revenue last quarter?

On Invalid Date, Bridgebio Pharma (NASDAQ: BBIO) reported Q3 2025 revenue of $120.70 million up 4,318.01% year over year. In the same quarter last year, Bridgebio Pharma's revenue was $2.73 million.

What was Bridgebio Pharma's revenue in 2024?

Bridgebio Pharma's annual revenue for the twelve months ending Dec 31, 2024 was $221.90 million, a 2,285.27% increase year over year.

How much does Bridgebio Pharma make in a day?

Based on Bridgebio Pharma annual revenue for the past five years, BBIO makes an average of $211,955.07 per day.

What was Bridgebio Pharma's annual revenue growth in the past year?

As of Q4 2025, Bridgebio Pharma's revenue has grown 62.46% year over year. This is 210.66 percentage points lower than the US Biotechnology industry revenue growth rate of 273.12%. Bridgebio Pharma's revenue in the past year totaled $353.78 million.

How much does Bridgebio Pharma make in a year?

Bridgebio Pharma's revenue by year for the past five years is:
  • Bridgebio Pharma's revenue for the twelve months ending Dec 31, 2024 was $221.90 million, a 2,285.27% increase year over year.
  • Bridgebio Pharma's annual revenue for Dec 31, 2023 was $9.30 million, a 88.02% decrease from 2022.
  • Bridgebio Pharma's annual revenue for 2022 was $77.65 million, a 11.38% increase from 2021.
  • Bridgebio Pharma's annual revenue for 2021 was $69.72 million, a 745.14% increase from 2020.
  • Bridgebio Pharma's annual revenue for 2020 was $8.25 million, a 79.66% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.